Literature DB >> 28408009

Estimating an EQ-5D-5L Value Set for China.

Nan Luo1, Gordon Liu2, Minghui Li3, Haijing Guan4, Xuejing Jin5, Kim Rand-Hendriksen6.   

Abstract

OBJECTIVES: To estimate a five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) value set for China using the health preferences of residents living in the urban areas of the country.
METHODS: The values of a subset of the EQ-5D-5L-defined health states (n = 86) were elicited using the time trade-off (TTO) technique from a sample of urban residents (n = 1271) recruited from five Chinese cities. In computer-assisted personal interviews, participants each completed 10 TTO tasks. Two additive and two multiplicative regression models were evaluated for their performance in describing the relationship between TTO values and health state characteristics using a cross-validation approach. Final values were generated using the best-performed model and a rescaling method.
RESULTS: The 8- and 9-parameter multiplicative models unanimously outperformed the 20-parameter additive model using a random or fixed intercept in predicting values for out-of-sample health states in the cross-validation analysis and their coefficients were estimated with lower standard errors. The prediction accuracies of the two multiplicative models measured by the mean absolute error and the intraclass correlation coefficient were very similar, thus favoring the more parsimonious model.
CONCLUSIONS: The 8-parameter multiplicative model performed the best in the study and therefore was used to generate the EQ-5D-5L value set for China. We recommend using rescaled values whereby 1 represents the value of instrument-defined full health in economic evaluation of health technologies in China whenever the EQ-5D-5L data are available.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D-5L; cross-validation; modeling; time trade-off

Mesh:

Year:  2017        PMID: 28408009     DOI: 10.1016/j.jval.2016.11.016

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  117 in total

1.  EQ-5D-5L Valuation for the Malaysian Population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo; Kim Rand-Hendriksen; Faridah Aryani Md Yusof
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

2.  Maternal tobacco exposure and health-related quality of life during pregnancy: a national-based study of pregnant women in China.

Authors:  Weiwei Sun; Xinyu Huang; Huailiang Wu; Casper J P Zhang; Zongzhi Yin; Qianqian Fan; Huiyun Wang; Pallavi Jayavanth; Babatunde Akinwunmi; Yanxin Wu; Zilian Wang; Wai-Kit Ming
Journal:  Health Qual Life Outcomes       Date:  2021-05-20       Impact factor: 3.186

3.  Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.

Authors:  Tong Liu; Shunping Li; Min Wang; Qiang Sun; Gang Chen
Journal:  Patient       Date:  2020-10       Impact factor: 3.883

4.  Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.

Authors:  Liu Liu; Shunping Li; Yue Zhao; Jianglin Zhang; Gang Chen
Journal:  Qual Life Res       Date:  2018-02-28       Impact factor: 4.147

5.  Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population.

Authors:  Thomas Patton; Hao Hu; Luan Luan; Keqin Yang; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2018-07-04       Impact factor: 4.147

6.  Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.

Authors:  Admassu N Lamu; Gang Chen; Thor Gamst-Klaussen; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2018-03-22       Impact factor: 4.147

7.  Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Yushan Wu; Siyue Yu; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Eur J Health Econ       Date:  2021-03-24

8.  Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.

Authors:  Jie Jiang; Yanming Hong; Tiantian Zhang; Zhihao Yang; Tengfei Lin; Zhuoru Liang; Peiyao Lu; Lishun Liu; Binyan Wang; Yongmei Xu; Nan Luo
Journal:  Qual Life Res       Date:  2021-04-05       Impact factor: 4.147

9.  Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.

Authors:  Juan Zhu; Xin-Xin Yan; Cheng-Cheng Liu; Hong Wang; Le Wang; Su-Mei Cao; Xian-Zhen Liao; Yun-Feng Xi; Yong Ji; Lin Lei; Hai-Fan Xiao; Hai-Jing Guan; Wen-Qiang Wei; Min Dai; Wanqing Chen; Ju-Fang Shi
Journal:  Qual Life Res       Date:  2020-09-15       Impact factor: 4.147

10.  Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China.

Authors:  Zhuoru Liang; Tiantian Zhang; Tengfei Lin; Lishun Liu; Binyan Wang; Alex Z Fu; Xiaobin Wang; Xiping Xu; Nan Luo; Jie Jiang
Journal:  Qual Life Res       Date:  2019-03-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.